Tara Troy
Northbrook, ILNPI 1306825740
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,537 of the $39,574 with a category attached, or 69.6%. Capsovision, Inc. accounts for 69.6% of it on its own, with 41 other manufacturers making up the rest. 2025 is the largest year on record at $29,524, more than ten times the $1,570 reported in 2019.
Across 598 payments — averaging $66.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Capsovision, Inc.$28K
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Pfizer$685
- plus $4K from 36 others
What the payments were for
- Consulting fees$27,53770%
- Food & beverage$11,62129%
- Education$3321%
- Other$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CapsoCam Plus$27,537
- Entyvio$112
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.